Skip to main content

Table 3 Effect of treatment of HDP on maternal mortality from HDP using severe acute maternal morbidity case fatality rates in low income countries

From: Quantifying the fall in mortality associated with interventions related to hypertensive diseases of pregnancy

Author, year

Study population (period)

Definition of HDP-related SAMM

Case fatality rate (Number of deaths/cases)

Mortality reductiona

    

Natural case fatality

    

25%

42%

Mantel et al, 1998[73]

Kalafong and Pretoria hospitals, South Africa (1996-1998)

Hypertension with organ failure

20.8% (10/48)

16.7%

50.4%

Khosla et al 2000[74]

One hospital, Rohtak, India (1998)

Eclampsia

17.7% (11/62)

29.0%

57.8%

Pattinson et al, 2003[75]

Three regions, South Africa (year not stated)

Hypertension with organ failure

20.7% (30/145)

17.2%

50.7%

Kaye et al 2003[76]

Mulago hospital, Uganda (2000)

Eclampsia/pre-eclampsia with organ failure

14.3% (3/21)

42.9%

66.0%

Oladapo et al 2007[77]

Olabisi Onabanjo hospital, southwest Nigeria (2002-2004)

Eclampsia and severe pre-eclampsia with clinical/laboratory indications for termination of pregnancy to save the woman's live

14.9% (21/141)

40.4%

64.5%

Adisasmita et al 2008[78]

Four hospitals in West-Java, Indonesia (2003-2004)

Eclampsia and pre-eclampsia with organ failure

3.9% (22/563)

84.4%

90.7%

Roost et al 2009[79]

Four public hospitals in La Paz and El Alto, Bolivia (2006-2007)

Eclampsia and pre-eclampsia based on clinical and management criteria

0.5% (1/184)

98.0%

98.8%

  1. a Mortality reduction was calculated as (Natural case fatality rate – SAMM fatality rate / Natural case fatality rate)